Angels Designate Mike Baumann For Assignment
The Angels announced that they have selected the contract of righty reliever Ryan Zeferjahn. In a corresponding roster move, fellow reliever Mike Baumann has been designated for assignment.
Baumann has ridden the DFA carousel throughout the season. The righty is out of options, so teams need to continue taking him off the 40-man roster if they nudge him out of the bullpen. No club has successfully gotten Baumann through waivers. He has gone from the Orioles to the Mariners, Giants and Halos via DFA resolutions throughout the year.
The 28-year-old hasn’t pitched especially well at any of those stops. He owns a cumulative 5.24 ERA through 44 2/3 innings. The Jacksonville product’s 19.5% strikeout percentage, 10.2% walk rate and 1.61 home runs per nine are all subpar. A few teams have nevertheless been intrigued by his still above-average velocity (96.4 MPH on the fastball) and last year’s decent results. He’s a season removed from a 3.76 ERA across 64 2/3 innings with Baltimore.
Baumann will land back on waivers in the next couple days. Any claiming team would need to keep him in the MLB bullpen. He surpassed the two-year service threshold this season and will play on a pre-arbitration salary for another year.
Zeferjahn, a University of Kansas product, steps into the vacated bullpen spot. The 6’5″ righty is a former third-round pick of the Red Sox. Command issues quickly pushed him to the bullpen, where Zeferjahn has shown strikeout stuff. He has fanned more than 28% of opponents in his five-year minor league career. That’s up to nearly 31% this season between the top two minor league levels. Zeferjahn carries a 3.33 earned run average across 46 innings on the season.
The Angels acquired him as part of a four-player return for reliever Luis García at the deadline. Three of them — Zeferjahn, outfielder Matthew Lugo and first baseman Niko Kavadas — were in the high minors at the time. Kavadas debuted last week. Los Angeles would have needed to add Zeferjahn to the 40-man this offseason to keep him out of the Rule 5 draft. They’ll give him his first big league opportunity a few weeks earlier than that as he tries to carve out a middle relief role going into next season.
Cubs Claim Gavin Hollowell, Designate David Bote
The Cubs have claimed right-hander Gavin Hollowell off waivers from the Diamondbacks and optioned him to Triple-A Iowa. The Snakes had designated him for assignment a few days ago. To open a 40-man roster spot, the Cubs have designated infielder David Bote for assignment. Paul Sullivan of the Chicago Tribune was among those to relay the news on X.
Hollowell, 26, was drafted by the Rockies and was with that organization until recently. The Diamondbacks claimed him off waivers in June and now he moves via another waiver claim, this time landing with the Cubs.
The interest from clubs likely stems from his big strikeout numbers in the minors, though he has also given out a large number of walks and hasn’t yet transferred those punchouts to the major league level.
The Rockies put him into 30 games over the 2022 and 2023 seasons and he pitched 40 2/3 innings with a 6.20 earned run average. He struck out 21.5% of batters faced in that time and gave out walks at an 11.8% rate. But since the start of 2023, he has thrown 47 minor league innings and struck out 27.9% of batters faced. That’s come with an elevated 13% walk rate and a 4.60 ERA, but clubs are always interested in missing bats.
He still has one option year after this one, so the Cubs could give him a lot of rope in the minors to see if he can rein in his stuff. If he does so, he has less than a year of service time and therefore comes with many years of club control and is still far away from qualifying for arbitration.
Bote, 31, signed an extension with the Cubs in April of 2019, a five-year pact that guaranteed him over $15MM. He served in a multi-positional role for a while but his results eventually tailed off, at least partially due to some injury troubles.
He was outrighted off the roster at the end of 2022 with two guaranteed years still left on his deal. Since he had more than three years of service time, he could have elected free agency, but doing so would have meant walking away from the remaining money on his contract since he was shy of the five-year service mark. Naturally, he stayed with the club and has been with them in a non-roster capacity until they selected his contract again in June.
He has a solid .304/.333/.391 batting line in his 48 plate appearances this year but that’s being held up by an unsustainable .424 batting average on balls in play. He has no home runs in that time and a 4.2% walk rate.
With the trade deadline now passed, the Cubs will have to put Bote on waivers in the coming days. It’s unlikely that any club would claim him and take on the remainder of his contract. He’s making $5.5MM this year with still roughly $1.1MM left to be paid out. There’s also a $1MM buyout on a $7MM club option for 2025.
Bote is still shy of five years of service time, meaning he still doesn’t have the right to reject an outright assignment and keep all of his money. Assuming he passes through waivers unclaimed, he will presumably accept another outright assignment and provide the Cubs with depth in a non-roster capacity.
Padres Reinstate Yu Darvish From Restricted List
The Padres announced that right-hander Yu Darvish has been reinstated from the restricted list and will join the club tonight, though he has been returned to the 15-day injured list. Infielder Matthew Batten was designated for assignment to open a 40-man roster spot for him.
Darvish, 38, began his season strong. He made 11 starts through the end of May, allowing 3.20 earned runs per nine innings, but his campaign has been on pause since then. He landed on the 15-day injured list June 1, retroactive to May 31, due to a left groin strain. He was supposed to return on June 25 but then was sidelined by some inflammation in his throwing elbow.
On July 6, he was transferred to the restricted list due to an undisclosed family matter, with no details about that situation having been made public. Last week, it was reported that Darvish set up a live BP session at a high school, trying to keep himself somewhat ready even while he was away from the club and perhaps demonstrating that he had put his injuries behind him. Whatever the family situation was, it now seems it has been resolved enough for the veteran to turn his attentions back to baseball.
However, he may not immediately join the big league club, as he is still on the injured list. After so much down time, he will likely need some kind of rehab assignment to build back up. Still, the fact that he is back from the restricted list at least provides some clarity and some expectations to a situation that was previously difficult to predict.
The Padres just optioned struggling knuckleballer Matt Waldron, leaving them with a rotation consisting of Joe Musgrove, Dylan Cease, Michael King and Martín Pérez. Whenever Darvish is in game shape, he will jump back into that mix. Until then, the club may need to call upon Randy Vásquez or Jhony Brito to cover Waldron’s spot, or perhaps deploy a bullpen game or two.
Batten, 29, was added to the club’s roster in June of 2022. He has largely been on optional assignment in the two-plus years since then, having appeared in 59 big league games with 164 plate appearances. He has hit .239/.337/.345 in those for a wRC+ of 96. His minor league work has actually been worse, as he has hit .242/.333/.372 at Triple-A El Paso since the start of 2023. In the context of the hitter-friendly Pacific Coast League, that translates to a wRC+ of 75.
He is in his final option year and will be out of options by next season. With the trade deadline having passed, the Friars will have to place him on waivers in the coming days. Despite the lack of offense, some club may be attracted to his other attributes. He has racked up double-digit steal totals in each minor league season since 2021 and has played every position on the diamond except catcher, including some mop-up duty on the mound. He has less than a year of service time and therefore could potentially be retained for six seasons beyond this one.
Red Sox Select Joely Rodríguez
The Red Sox announced that they have selected the contract of left-hander Joely Rodríguez. Right-hander Greg Weissert was optioned to Triple-A Worcester in a corresponding active roster move. To open a 40-man roster spot, lefty James Paxton was transferred to the 60-day injured list. Jen McCaffrey of The Athletic was among those to relay the moves on X.
Rodríguez, 32, signed a minor league deal with the Red Sox in the offseason. He cracked their Opening Day roster but didn’t post strong results initially. He made 11 appearances for the club with a 6.55 earned run average, the same numbers he had in limited time with them last year.
He was designated for assignment at the end of April and accepted an outright assignment after clearing waivers. He then spent about six weeks on the minor league injured list from the middle of May until late June. That has left him with just 14 1/3 Triple-A innings pitched this year, but with a strong 1.88 ERA. There’s likely a good deal of fortune in there, based on his .175 batting average on balls in play in that small sample. His 20.6% strikeout rate and 12.7% walk rate in that time were subpar, though he did get grounders at a strong 52.6% clip.
Those rate stats aren’t too far off of his major league track record. In 168 innings dating back to his 2016 debut, he has a 4.82 ERA, 22.8% strikeout rate, 10.1% walk rate and 55.7% ground ball rate. He’ll give the club a second lefty in the bullpen alongside Brennan Bernardino. He is out of options but can be retained beyond this season via arbitration if he holds onto his roster spot through the end of the year.
As for Paxton, it’s not a surprise to see him moved to the 60-day IL. He suffered a partially torn right calf muscle last week and manager Alex Cora said it was unlikely that the lefty would be able to return this year. He’s now officially ineligible to be reinstated until the second week of October. Unless the Sox make a deep playoff run and he heals up in the next two months, his season is over.
Rockies Select Luis Peralta
The Rockies announced that they have selected the contract of left-hander Luis Peralta. In corresponding moves, they optioned right-hander Tanner Gordon to Triple-A Albuquerque and transferred righty Germán Márquez to the 60-day injured list.
Peralta, 23, was just acquired from the Pirates last month in the Jalen Beeks trade. The younger brother of Brewers ace Freddy Peralta, Luis signed with the Pirates out of the Dominican Republic in 2017. He came up as a starter but has been moved into a relief role this year, with some encouraging results.
He has pitched at High-A, Double-A and Triple-A this year between his two organizations. Between all those different stops, he has logged 47 2/3 innings while only allowing five earned runs for a tiny ERA of 0.94. His 11.2% walk rate in that time is a bit high but he’s worked around that by striking out 40.1% of batters that have stepped to the plate.
He was going to be eligible for the Rule 5 draft this winter and was likely going to get a roster spot in a few months’ time anyway, so the Rockies are jumping the gun and adding him now, which will allow them to get a look at him against major league hitters for a few weeks.
Gordon had been working out of the club’s rotation, so they will now have a hole there behind Cal Quantrill, Kyle Freeland, Austin Gomber and Bradley Blalock. Right-hander Ryan Feltner landed on the 15-day IL on August 8 due to a right shoulder strain but could perhaps be coming back. Patrick Lyons of Just Baseball relayed on X last week that Feltner’s MRI came back clean and he could be back after something close to a minimal stint. He made a rehab appearance for Triple-A Albuquerque on Wednesday.
As for Marquez, it was reported a couple of weeks ago that he won’t be coming back this year due to some elbow inflammation, so this transfer to the 60-day IL was an inevitable formality. He’ll be on the 60-day IL for the rest of the year but will need to be reinstated in the days following the World Series, as the IL goes away until Spring Training.
Reds Place Andrew Abbott On Injured List Due To Shoulder Strain
The Reds announced that left-hander Andrew Abbott has been placed on the 15-day injured list, retroactive to August 20, due to a left shoulder strain. Right-hander Alan Busenitz has been selected to take his place on the roster. To open a 40-man spot for Busenitz, catcher Austin Wynns has been transferred to the 60-day injured list.
At this point, the club hasn’t provided any information on when Abbott suffered the injury or how long they expect him to be out. He last took the ball on Sunday, tossing 83 pitches over five innings. His velocity was down a bit, per Statcast, with his fastball averaging 91.6 miles per hour. He was at 92.6 mph the previous start, perhaps indicating he wasn’t 100% last time out.
Regardless, it’s an unfortunate development for the Reds and their rotation. Abbott has been a mainstay this year, with a 3.72 ERA over his 25 starts on the season. Him and Hunter Greene are the two team leaders in innings but Greene landed on the IL last week due to elbow soreness. With Abbott now joining Greene on the IL, the club is without the two pillars of their rotation. That’s on top of Graham Ashcraft and Brandon Williamson, who are also on the IL.
Absences have been a key storyline for the Reds this year. In addition to those pitching issues, their position player mix currently has Wynns, Jeimer Candelario, Jake Fraley, Christian Encarnacion-Strand, Matt McLain and Nick Martini on the IL. They also didn’t have Noelvi Marté for the first 80 games of the year due to a PED suspension, lost TJ Friedl to the IL for a while, amid other issues.
Despite those challenges, the club is 63-64 and hanging in the playoff race. They are currently five games back of Atlanta for the final postseason spot in the National League, but staying afloat will be more challenging with the rotation in such trouble. Abbott was the scheduled starter today, so the club may have to do some kind of bullpen game, then proceed with a rotation consisting of Nick Lodolo, Nick Martinez, Carson Spiers and Julian Aguiar. Spiers and Martinez are swingmen who have moved into rotation roles due to injuries while Aguiar was just called up and has one major league start to his name.
The club has an off-day on Monday but then plays eight games in seven days thanks to a double-header next Friday, meaning they may have to call upon some depth. Lyon Richardson is on the 40-man roster but has been pitching in relief lately. Connor Phillips has a 9.92 ERA in Triple-A this year and just returned from a two-month stint at the club’s spring complex trying to get back on track. Prospect Rhett Lowder is at Triple-A but was just promoted there and has only one start at that level. Justus Sheffield is around in a non-roster capacity but has a 6.88 ERA in Triple-A this year.
For now, Busenitz will give the club a fresh arm for their bullpen. He signed a minor league deal with the club in January and has logged 55 innings over 40 Triple-A appearances this year. He has a 3.93 ERA in that time, along with a 22.3% strikeout rate and 7.9% walk rate. He is out of options and can’t be sent back down to the minors without first being exposed to waivers.
Wynns landed on the 10-day IL at the end of July due to a lat strain. It seems the club isn’t expecting him back any time soon, as he’s now ineligible to return until the final days of the regular season.
Front Office Subscriber Chat Transcript
MLBTR’s Anthony Franco held a live chat this afternoon, exclusively for Trade Rumors Front Office subscribers.
Unlock Subscriber-Exclusive Articles Like This One With a Trade Rumors Front Office Subscription
- Access weekly subscriber-only articles by Tim Dierkes, Steve Adams, and Anthony Franco.
- Join exclusive weekly live chats with Anthony.
- Remove ads and support our writers.
- Access GM-caliber tools like our MLB Contract Tracker
Astros Shut Down Penn Murfee’s Rehab Assignment
Right-hander Penn Murfee began a rehab assignment last week but made just one appearance and will now be shut down. Per Matt Kawahara of the Houston Chronicle, the righty has been returned from that rehab assignment due to what the team calls “a reoccurrence of right elbow discomfort.”
Murfee, now 30, got out to a strong start in his major league career. He made 80 appearances for the Mariners over the 2022 and 2023 seasons with a 2.70 earned run average. He posted a strong 27.9% strikeout rate in that time, with his 8.5% walk rate close to league average.
The latter of those two seasons was cut short midway through, as he underwent Tommy John surgery in July of last year. In the offseason, the M’s put him on waivers and he was claimed by the Mets and then Atlanta. The latter club non-tendered him, re-signed him to a split deal and then put him back on waivers, at which point the Astros claimed him.
Houston was undoubtedly hoping Murfee could provide a second-half jolt to their bullpen once he recovered from his surgery, but that’s looking less likely now. “It’s not ideal,” manager Joe Espada said. “It sucks because I know he’s worked really hard. He wants to get on the field, he wants to pitch for us this season. I still expect him to do it. It’s just, we’re going to have to slow him down a little bit here and see how he feels. It’s day to day right now.”
It seems Espada still left the window open for Murfee to come back this year, but it’ll be tight just based on the calendar. Whenever he’s cleared to restart his rehab, he’ll presumably need a few outings to get into game shape after so much down time. The Astros have taken the lead in the West division and could perhaps increase the chances of Murfee playing a role if they manage to play deep into October yet again.
Even if that doesn’t come to pass, Murfee could play a role on the club in the future. He came into this season with one year and 169 days of service time. Players on the major league injured list collect service time, so he’ll finish this year at 2.169 as long as he’s not activated and then optioned in the next few weeks. He will qualify for arbitration as a Super Two player this winter but won’t be able to command a huge raise after so much missed time. The Astros can control him for four additional seasons beyond this one.
In another bit of Astros news, Chandler Rome of The Athletic relays on X that the club is going to give Alex Bregman some reps at first base. He recently missed a few games due to right elbow inflammation but has been in the last two contests as the designated hitter. Shay Whitcomb has been covering the hot corner of late while Bregman’s elbow is preventing him from making strong throws across the diamond, but perhaps he could handle first, where the throwing demands are lower.
While the club is surely glad to have Bregman’s bat back in the lineup, it currently makes for a slightly awkward fit as it forces Yordan Alvarez to play the field every day. The club has also given some DH time to Yainer Diaz this year, keeping his bat in the lineup whenever Victor Caratini is catching. If Bregman could slot in at first from time to time, it could give Espada a bit more flexibility in setting the lineup, getting Alvarez and Diaz a lighter workload as they approach the postseason.
First base has been a bit hole for the club this year, with José Abreu having been released after his immense struggles. Jon Singleton has largely taken over, with Zach Dezenzo also factoring in lately and Diaz moving there on occasion as well. Singleton is hitting .234/.314/.369 this year for a wRC+ of 97, almost league average but a bit below the expectations for a first baseman. Dezenzo has hit .188/.235/.313 in a small sample of 34 plate appearances. Bregman has hit .261/.319/.448 this year for a 117 wRC+ but has been even better lately. After cold start to the season, he has hit .296/.351/.512 since the start of June for a 145 wRC+.
Max Scherzer Scratched From Planned Rehab Start
Rangers right-hander Max Scherzer was scheduled to make a rehab outing for Double-A Frisco tonight but that will no longer happen. Per Evan Grant of the Dallas Morning News, the veteran has been scratched from that start, with the club providing little information about his current status.
It’s been a challenging season for Scherzer, who has never really dealt with a significant injury before. Apart from his 2008 debut and the shortened 2020 season, he has never thrown less than 145 1/3 innings in a major league season. He logged at least 170 frames in each full season from 2009 to 2021.
But he is certainly going to fall short of that range this year. He has thrown 39 1/3 innings in the majors and he’s running out of time to add to that total. He underwent back surgery in the offseason and it was initially hoped that he could be back at some point in May, but that didn’t come to pass.
He began a rehab assignment in late April but that was halted after just one outing due to some soreness in his right thumb. Grant relayed on May 11 that Scherzer was dealing with a nerve issue running down his arm and had received a cortisone injection. Grant provided an update in a May 15 column, noting that Scherzer had received a Botox injection, a treatment for neurogenic thoracic outlet syndrome but also other nerve pain. In a May 28 column, Grant noted that neurogenic TOS normally features pain going from the shoulder to the finger but Scherzer’s case was the opposite, with pain going up his arm from his thumb. In another update on May 31, Grant again mentioned neurogenic TOS but noted that Scherzer has maintained the issue is not TOS.
Scherzer was eventually able to get healthy enough to get on the mound. He made two more rehab starts in June and was reinstated from the injured list that month. He made eight starts at the big league level, throwing the aforementioned 39 1/3 innings, allowing 3.89 earned runs per nine. But in the first week of August, he landed back on the IL due to some right shoulder fatigue. As mentioned, he was planned to start a rehab assignment tonight but that won’t happen now.
It’s undoubtedly a frustrating experience for Scherzer with the constant starting and stopping this year, but there’s little reason for the club to push him at this point if he’s not 100%. The club is 59-69 and 10.5 games back of the Astros in the West. Both the Playoff Odds at FanGraphs and the PECOTA Standings at Baseball Prospectus put their chances of cracking the postseason at less than a half of a percentage point.
With their season more or less on life support, the club and Scherzer can focus on his long-term health. As of last week, the 40-year-old said he was planning to pitch again in 2025. He won’t take the hill tonight and further developments will undoubtedly be forthcoming in the next few weeks.
Scherzer is scheduled to hit free agency at season’s end and is health status will likely play a key role in how the winter plays out for him. Plenty of clubs would be interested in him based on his amazing track record but the mention of neurogenic TOS will undoubtedly raise some flags. Last summer, Jesse Dougherty of The Washington Post looked at the two different kinds of TOS and why the results are often so divergent. Merrill Kelly once had venous TOS but was able to recover and has pitch at a high level for years afterwards. Whereas neurogenic TOS is often more debilitating, with pitchers like Stephen Strasburg significantly hampered by the condition.
Again, Scherzer has insisted he is not dealing with neurogenic TOS, though he does have a nerve issue of some kind. Whatever is ailing him, it’s been a significant roadblock this year. He will undoubtedly be exploring all avenues with medical experts in the coming weeks to find a path forward towards his goal of pitching next year. As of today, he has a 3.16 ERA in almost 3,000 career innings pitched and is tenth on the all-time strikeout list.
Yankees Reinstate Jazz Chisholm
August 23: The Yankees have now made it official by announcing Chisholm’s reinstatement.
August 22: The Yankees will activate Jazz Chisholm Jr. from the injured list tomorrow, reports Andy Martino of SNY (on X). New York optioned Oswald Peraza back to Triple-A this evening to open an active roster spot.
It’s a remarkably quick turnaround. Chisholm’s season initially looked as if it could be in jeopardy when he damaged the UCL in his left (non-throwing elbow) a couple weeks ago. The Yankees quickly made clear they expected Chisholm back this year, although they didn’t anticipate this level of progress. As recently as last Friday, New York’s big deadline acquisition was reportedly targeting a return at some point in September.
Barring a last-minute change of plans, Chisholm will instead get back on the diamond after a minimal stint. He’ll draw back in at third base, where Peraza and Oswaldo Cabrera have split the work over the last week and a half. That could be a significant boost to the New York lineup. Chisholm had been on an absolute tear early in his tenure in the Bronx. He already has seven homers with a .316/.361/.702 slash in 14 games as a Yankee.
Chisholm isn’t the only player who should soon return to the Yankee infield. Anthony Rizzo and Jon Berti are each scheduled to begin rehab assignments in the next few days (per the MLB.com injury tracker). Berti is headed to Double-A Somerset tomorrow; Rizzo is expected to join him there at some point this weekend. Position players can spend up to 20 days on a minor league rehab assignment.
Both Berti and Rizzo are on the 60-day injured list and have been out for multiple months. The former has only played in 17 games since the Yankees acquired him from Miami in a trade around Opening Day. Berti has been out since late May after suffering a significant strain in his left calf. Rizzo broke his right arm in a collision with Red Sox pitcher Brennan Bernardino in mid-June.
The Yankees called up 25-year-old Ben Rice to handle the majority of the first base work after that. Rice has struggled in his first look at MLB pitching, running a .180/.279/.374 slash. The rookie had a three-homer game against Boston last month but only has four longballs in his other 44 contests.